Contributors
GERARD AGBAYANI • Human Health Therapeutics, National Research Council Canada,
Ottawa, ON, Canada
BASSEL AKACHE • Human Health Therapeutics, National Research Council Canada,
Ottawa, ON, Canada
RIYAD F. ALZHRANI • Division of Molecular Pharmaceutics and Drug Delivery, College of
Pharmacy, The University of Texas at Austin, Austin, TX, USA
VASCO AZEVEDO • Laboratory of Cellular and Molecular Genetics (LGCM), Department of
Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of
Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
VIVIANE LIMA BATISTA • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
MARIE BEITELSHEES • Department of Chemical and Biological Engineering, The State
University of New York at Buffalo, Buffalo, NY, USA
MONIKA BERGER • Institute of Clinical Biochemistry, Hannover Medical School, Hannover,
Germany
MANMEET BHALLA • Department of Microbiology and Immunology, University at Buffalo
School of Medicine, Buffalo, NY, USA
FADIL A. BIDMOS • Section of Paediatric Infectious Disease, Department of Infectious Disease,
Imperial College London, London, UK
ELSA N. BOU GHANEM • Department of Microbiology and Immunology, University at
Buffalo School of Medicine, Buffalo, NY, USA
DANIEL G. BRACEWELL • Department of Biochemical Engineering, University College
London, London, UK
NORICA BRANZA-NICHITA • Institute of Biochemistry of the Romanian Academy, Bucharest,
Romania
INSA BUDDE • Institute of Clinical Biochemistry, Hannover Medical School, Hannover,
Germany
DIPSHIKHA CHAKRAVORTTY • Department of Microbiology and Cell Biology, Indian Institute
of Science, Bengaluru, India; Centre for Biosystems Science and Engineering, Indian
Institute of Science, Bengaluru, India
YANPING CHEN • Center of Emphasis in Infectious Diseases, Department of Molecular and
Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health
Sciences Center El Paso, El Paso, TX, USA
OSCAR CONCHILLO-SOLE ´ • Institute of Biotechnology and Biomedicine, Universitat
Auto `noma de Barcelona, Cerdanyola del Valle `s, Spain; Department of Genetics and
Microbiology, Universitat Auto `noma de Barcelona, Cerdanyola del Valle `s, Spain
ZHENGRONG CUI • Division of Molecular Pharmaceutics and Drug Delivery, College of
Pharmacy, The University of Texas at Austin, Austin, TX, USA
PETER CZERMAK • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany; Faculty of Biology and Chemistry, Justus-Liebig-University Giessen,
xi
GERARD AGBAYANI • Human Health Therapeutics, National Research Council Canada,
Ottawa, ON, Canada
BASSEL AKACHE • Human Health Therapeutics, National Research Council Canada,
Ottawa, ON, Canada
RIYAD F. ALZHRANI • Division of Molecular Pharmaceutics and Drug Delivery, College of
Pharmacy, The University of Texas at Austin, Austin, TX, USA
VASCO AZEVEDO • Laboratory of Cellular and Molecular Genetics (LGCM), Department of
Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of
Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
VIVIANE LIMA BATISTA • Laboratory of Cellular and Molecular Genetics (LGCM),
Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal
University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil
MARIE BEITELSHEES • Department of Chemical and Biological Engineering, The State
University of New York at Buffalo, Buffalo, NY, USA
MONIKA BERGER • Institute of Clinical Biochemistry, Hannover Medical School, Hannover,
Germany
MANMEET BHALLA • Department of Microbiology and Immunology, University at Buffalo
School of Medicine, Buffalo, NY, USA
FADIL A. BIDMOS • Section of Paediatric Infectious Disease, Department of Infectious Disease,
Imperial College London, London, UK
ELSA N. BOU GHANEM • Department of Microbiology and Immunology, University at
Buffalo School of Medicine, Buffalo, NY, USA
DANIEL G. BRACEWELL • Department of Biochemical Engineering, University College
London, London, UK
NORICA BRANZA-NICHITA • Institute of Biochemistry of the Romanian Academy, Bucharest,
Romania
INSA BUDDE • Institute of Clinical Biochemistry, Hannover Medical School, Hannover,
Germany
DIPSHIKHA CHAKRAVORTTY • Department of Microbiology and Cell Biology, Indian Institute
of Science, Bengaluru, India; Centre for Biosystems Science and Engineering, Indian
Institute of Science, Bengaluru, India
YANPING CHEN • Center of Emphasis in Infectious Diseases, Department of Molecular and
Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health
Sciences Center El Paso, El Paso, TX, USA
OSCAR CONCHILLO-SOLE ´ • Institute of Biotechnology and Biomedicine, Universitat
Auto `noma de Barcelona, Cerdanyola del Valle `s, Spain; Department of Genetics and
Microbiology, Universitat Auto `noma de Barcelona, Cerdanyola del Valle `s, Spain
ZHENGRONG CUI • Division of Molecular Pharmaceutics and Drug Delivery, College of
Pharmacy, The University of Texas at Austin, Austin, TX, USA
PETER CZERMAK • Institute of Bioprocess Engineering and Pharmaceutical Technology
(IBPT), Technische Hochschule Mittelhessen (THM) - University of Applied Sciences,
Giessen, Germany; Faculty of Biology and Chemistry, Justus-Liebig-University Giessen,
xi